Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on April 14, 2025
Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025
GlobeNewswire
·
April 14, 2025
MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …
Venus Concept Raises a Total of Approximately $2.7 Million in Gross Proceeds from Previously Announced Registered Direct Offerings of Common Stock
GlobeNewswire
·
April 14, 2025
TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering priced at-the …
NeuroPace Provides Update on Tariff Status
GlobeNewswire
·
April 14, 2025
-- Minimal expected impact to operations and financial results -- -- Company to report first quarter 2025 financial results on May 13, 2025 -- MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device …
Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results
GlobeNewswire
·
April 14, 2025
KIRKLAND, Wash., April 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, today reported financial results for the third quarter fiscal 2025, which ended …
Can-Fite Announces $3.0 Million Registered Direct Offering of American Depositary Shares
GlobeNewswire
·
April 14, 2025
RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases (“Can-Fite” or the …
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
GlobeNewswire
·
April 14, 2025
WARREN, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announces CEO Dr. Ryan Saadi, MD, MPH, will participate in BioNJ’s Fifteenth Annual Bio Partnering Conference. Dr. Saadi will be …
31st annual Enserva STARS & Spurs Gala raises more than $1.7 million for STARS
GlobeNewswire
·
April 14, 2025
CALGARY, Alberta, April 14, 2025 (GLOBE NEWSWIRE) -- The Enserva STARS …
Psoriasis Market Outlook in the 7MM Through 2034: In-Depth Analysis by Psoriasis Type | DelveInsight
GlobeNewswire
·
April 14, 2025
New York, USA, April 14, 2025 (GLOBE NEWSWIRE) -- Psoriasis Market Outlook in the 7MM Through 2034: In-Depth Analysis by Psoriasis Type | DelveInsight The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near …
Epilepsy Community Unites to Oppose Cuts to Crucial Federal Epilepsy Programs
GlobeNewswire
·
April 14, 2025
BOWIE, Md., April 14, 2025 (GLOBE NEWSWIRE) -- The 118 undersigned organizations – representing people living with epilepsy; caregivers and loved ones; physicians, care providers, and epilepsy centers; epilepsy researchers; and others – are united in …
Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders
GlobeNewswire
·
April 14, 2025
HOUSTON, TX, April 14, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, is pleased to announce that the United States Patent and …
AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease
GlobeNewswire
·
April 14, 2025
PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE Paris, April 14, 2025, 6pm CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the United …
AB Science reçoit un avis d’acceptation pour le brevet américain courant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose
GlobeNewswire
·
April 14, 2025
COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS D'ACCEPTATION POUR LE BREVET AMERICAIN COUVRANT JUSQU'EN 2040 LE MASITINIB DANS LE TRAITEMENT DE LA DREPANOCYTOSE Paris, 14 avril 2025, 18h AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui que …
Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics
GlobeNewswire
·
April 14, 2025
STAMFORD, Conn., April 14, 2025 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that its Board of Directors (the “Board”) has approved a 1-for-3 reverse stock split of its outstanding shares of common stock. Cara …
Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country
GlobeNewswire
·
April 14, 2025
Saint Herblain (France), April 14, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose vaccine IXCHIQ …
Valneva reçoit la première autorisation de mise sur le marché pour IXCHIQ® dans un pays où le chikungunya est endémique
GlobeNewswire
·
April 14, 2025
Saint Herblain (France), le 14 avril 2025 - Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l'agence de santé brésilienne (ANVISA) a accordé l'autorisation de mise sur le marché à son …
Prostadine Drops Reviews [We Tested It] Read Ingredients, Side Effects for Urinary System
GlobeNewswire
·
April 14, 2025
ST. PETERSBURG, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Prostadine The Natural Solution for Prostate Health - As men age, prostate health often becomes a significant concern. The prostate, a small, walnut-sized gland in the male reproductive system, plays …
Johnson & Johnson’s Oral IL-23, Icotrokinra, Poised to Redefine the Psoriasis Treatment Landscape Following Positive Phase 3 Data, According to Spherix Global Insights
GlobeNewswire
·
April 14, 2025
EXTON, PA, April 14, 2025 (GLOBE NEWSWIRE) -- Johnson …
[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
GlobeNewswire
·
April 14, 2025
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules – corrected: reference to date of product launch in Europe removed; link to “Important Safety Information” updated Company aims to accelerate access to much-needed biosimilar to …
Positron Corporation Secures Agreement to Sell Four PET-CT Scanners
GlobeNewswire
·
April 14, 2025
Niagara Falls, NY, April 14, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical services, is pleased to …
Milwaukee's Underserved Communities Benefit from Outreach Community Health Center’s Use of the CHESS Health Platform
GlobeNewswire
·
April 14, 2025
Rochester, New York, April 14, 2025 (GLOBE NEWSWIRE) -- CHESS Health proudly announces a partnership with Outreach Community Health Centers (OCHC), a Federally Qualified Health Center (FQHC) based in Milwaukee, Wisconsin. This partnership is particularly …